Mail-order access to mifepristone, a Federal Drug Administration-approved abortion pill, would no longer be available, based on a ruling of the U.S. Court of Appeals for the Fifth Circuit.

Circuit Judge Jennifer Walker Elrod delivered the ruling Wednesday in Alliance for Hippocratic Medicine v. Food & Drug Administration, vacating a district court order in part and affirming in part.